Teenagers and young adults taking high doses of prescription amphetamines may face a greater than fivefold increased risk of developing psychosis or mania, a new analysis […]

Researchers have discovered that a brain network involved in reward processing and attention to stimuli is markedly bigger in people with depression, remains stable over time, […]

(Reuters) – The U.S. Drug Enforcement Administration (DEA) has increased the production limit for Takeda Pharmaceutical’s ADHD drug Vyvanse and its generic versions by about 24% […]

A growing amount of data is demonstrating that new fathers are likely to develop depression in the perinatal period. Anxiety and stress during fatherhood receive less […]

The US Food and Drug Administration’s (FDA) decision not to approve midomafetamine-assisted therapy (MDMA-AT) for posttraumatic stress disorder (PTSD) puts the therapy’s near-term future in doubt, […]

When parents are perceived as distracted by their phones or other technology during social or family interactions, it can affect the mental health of children between […]

Immigrants are gradually becoming the face of Canada. Today, the nation boasts one of the world’s highest immigration rates, with roughly 500,000 people entering Canada annually. […]